nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—lung cancer	0.327	1	CbGaD
Fingolimod—CYP2D6—Gefitinib—lung cancer	0.0242	0.112	CbGbCtD
Fingolimod—CYP2E1—Etoposide—lung cancer	0.0217	0.101	CbGbCtD
Fingolimod—CYP2D6—Vinorelbine—lung cancer	0.0187	0.0864	CbGbCtD
Fingolimod—CYP3A4—Topotecan—lung cancer	0.0168	0.0779	CbGbCtD
Fingolimod—S1PR1—umbilical vein—lung cancer	0.0163	0.153	CbGeAlD
Fingolimod—CYP3A4—Gefitinib—lung cancer	0.0154	0.0713	CbGbCtD
Fingolimod—CYP3A4—Teniposide—lung cancer	0.0149	0.0691	CbGbCtD
Fingolimod—CYP2D6—Erlotinib—lung cancer	0.0143	0.0663	CbGbCtD
Fingolimod—CYP3A4—Vinorelbine—lung cancer	0.0119	0.0549	CbGbCtD
Fingolimod—CYP2D6—Vinblastine—lung cancer	0.0115	0.0532	CbGbCtD
Fingolimod—CYP3A4—Crizotinib—lung cancer	0.00944	0.0437	CbGbCtD
Fingolimod—CYP3A4—Erlotinib—lung cancer	0.00911	0.0421	CbGbCtD
Fingolimod—S1PR5—mammary gland—lung cancer	0.00848	0.08	CbGeAlD
Fingolimod—CYP3A4—Paclitaxel—lung cancer	0.00834	0.0386	CbGbCtD
Fingolimod—CYP3A4—Irinotecan—lung cancer	0.00823	0.0381	CbGbCtD
Fingolimod—CYP3A4—Vinblastine—lung cancer	0.00731	0.0338	CbGbCtD
Fingolimod—CYP2D6—Doxorubicin—lung cancer	0.00707	0.0327	CbGbCtD
Fingolimod—CYP3A4—Etoposide—lung cancer	0.00659	0.0305	CbGbCtD
Fingolimod—S1PR1—mammary gland—lung cancer	0.00621	0.0586	CbGeAlD
Fingolimod—SPHK1—mammary gland—lung cancer	0.00615	0.058	CbGeAlD
Fingolimod—CYP3A4—Docetaxel—lung cancer	0.00603	0.0279	CbGbCtD
Fingolimod—CYP4F2—respiratory system—lung cancer	0.0053	0.05	CbGeAlD
Fingolimod—CYP3A4—Doxorubicin—lung cancer	0.00449	0.0208	CbGbCtD
Fingolimod—S1PR1—respiratory system—lung cancer	0.00414	0.0391	CbGeAlD
Fingolimod—S1PR4—bone marrow—lung cancer	0.00394	0.0372	CbGeAlD
Fingolimod—CYP4F2—trachea—lung cancer	0.00391	0.0369	CbGeAlD
Fingolimod—S1PR4—lung—lung cancer	0.00357	0.0337	CbGeAlD
Fingolimod—S1PR1—epithelium—lung cancer	0.00346	0.0327	CbGeAlD
Fingolimod—SPHK1—bronchus—lung cancer	0.00337	0.0318	CbGeAlD
Fingolimod—S1PR3—cardiac atrium—lung cancer	0.00326	0.0308	CbGeAlD
Fingolimod—CYP4F12—bronchus—lung cancer	0.00324	0.0306	CbGeAlD
Fingolimod—CYP4F2—bone marrow—lung cancer	0.0031	0.0293	CbGeAlD
Fingolimod—SPHK1—trachea—lung cancer	0.00303	0.0286	CbGeAlD
Fingolimod—CYP4F12—trachea—lung cancer	0.00291	0.0274	CbGeAlD
Fingolimod—CYP4F12—cardiac atrium—lung cancer	0.00273	0.0258	CbGeAlD
Fingolimod—S1PR3—lung—lung cancer	0.00249	0.0235	CbGeAlD
Fingolimod—S1PR4—lymph node—lung cancer	0.00244	0.0231	CbGeAlD
Fingolimod—CYP4F12—bone marrow—lung cancer	0.00231	0.0218	CbGeAlD
Fingolimod—S1PR1—lung—lung cancer	0.0022	0.0207	CbGeAlD
Fingolimod—SPHK1—lung—lung cancer	0.00218	0.0205	CbGeAlD
Fingolimod—CYP4F12—lung—lung cancer	0.00209	0.0197	CbGeAlD
Fingolimod—S1PR5—lymph node—lung cancer	0.00205	0.0194	CbGeAlD
Fingolimod—S1PR3—lymph node—lung cancer	0.00171	0.0161	CbGeAlD
Fingolimod—S1PR1—lymph node—lung cancer	0.0015	0.0142	CbGeAlD
Fingolimod—SPHK1—lymph node—lung cancer	0.00149	0.014	CbGeAlD
Fingolimod—CYP4F12—lymph node—lung cancer	0.00143	0.0135	CbGeAlD
Fingolimod—CYP2E1—respiratory system—lung cancer	0.000664	0.00626	CbGeAlD
Fingolimod—CYP2E1—lung—lung cancer	0.000353	0.00333	CbGeAlD
Fingolimod—Angiopathy—Irinotecan—lung cancer	0.000249	0.00158	CcSEcCtD
Fingolimod—Depression—Paclitaxel—lung cancer	0.000249	0.00157	CcSEcCtD
Fingolimod—Paraesthesia—Topotecan—lung cancer	0.000248	0.00157	CcSEcCtD
Fingolimod—Cardiac disorder—Gemcitabine—lung cancer	0.000248	0.00157	CcSEcCtD
Fingolimod—Mediastinal disorder—Irinotecan—lung cancer	0.000247	0.00157	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Docetaxel—lung cancer	0.000247	0.00156	CcSEcCtD
Fingolimod—Dyspnoea—Topotecan—lung cancer	0.000246	0.00156	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000245	0.00155	CcSEcCtD
Fingolimod—Connective tissue disorder—Cisplatin—lung cancer	0.000245	0.00155	CcSEcCtD
Fingolimod—Dyspnoea—Erlotinib—lung cancer	0.000244	0.00154	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—lung cancer	0.000243	0.00154	CcSEcCtD
Fingolimod—Angiopathy—Gemcitabine—lung cancer	0.000242	0.00154	CcSEcCtD
Fingolimod—Alopecia—Irinotecan—lung cancer	0.000242	0.00154	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Docetaxel—lung cancer	0.000242	0.00153	CcSEcCtD
Fingolimod—Mediastinal disorder—Gemcitabine—lung cancer	0.000241	0.00153	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Topotecan—lung cancer	0.000239	0.00151	CcSEcCtD
Fingolimod—Fatigue—Topotecan—lung cancer	0.000238	0.00151	CcSEcCtD
Fingolimod—Alopecia—Gemcitabine—lung cancer	0.000236	0.0015	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Erlotinib—lung cancer	0.000236	0.00149	CcSEcCtD
Fingolimod—Fatigue—Erlotinib—lung cancer	0.000236	0.00149	CcSEcCtD
Fingolimod—Infection—Vinorelbine—lung cancer	0.000235	0.00149	CcSEcCtD
Fingolimod—Sinusitis—Paclitaxel—lung cancer	0.000234	0.00148	CcSEcCtD
Fingolimod—Headache—Teniposide—lung cancer	0.000234	0.00148	CcSEcCtD
Fingolimod—Eye disorder—Cisplatin—lung cancer	0.000233	0.00147	CcSEcCtD
Fingolimod—Nervous system disorder—Vinorelbine—lung cancer	0.000232	0.00147	CcSEcCtD
Fingolimod—Cardiac disorder—Cisplatin—lung cancer	0.000231	0.00146	CcSEcCtD
Fingolimod—Back pain—Irinotecan—lung cancer	0.000231	0.00146	CcSEcCtD
Fingolimod—Skin disorder—Vinorelbine—lung cancer	0.00023	0.00145	CcSEcCtD
Fingolimod—Bradycardia—Paclitaxel—lung cancer	0.000228	0.00144	CcSEcCtD
Fingolimod—Back pain—Gemcitabine—lung cancer	0.000225	0.00143	CcSEcCtD
Fingolimod—Mediastinal disorder—Cisplatin—lung cancer	0.000224	0.00142	CcSEcCtD
Fingolimod—Hypotension—Vinorelbine—lung cancer	0.000221	0.0014	CcSEcCtD
Fingolimod—Alopecia—Cisplatin—lung cancer	0.00022	0.00139	CcSEcCtD
Fingolimod—Connective tissue disorder—Paclitaxel—lung cancer	0.00022	0.00139	CcSEcCtD
Fingolimod—Weight decreased—Docetaxel—lung cancer	0.000214	0.00136	CcSEcCtD
Fingolimod—Leukopenia—Irinotecan—lung cancer	0.000214	0.00135	CcSEcCtD
Fingolimod—Eye disorder—Etoposide—lung cancer	0.000213	0.00135	CcSEcCtD
Fingolimod—Pneumonia—Docetaxel—lung cancer	0.000212	0.00135	CcSEcCtD
Fingolimod—Paraesthesia—Vinorelbine—lung cancer	0.000212	0.00134	CcSEcCtD
Fingolimod—Cardiac disorder—Etoposide—lung cancer	0.000212	0.00134	CcSEcCtD
Fingolimod—Infestation NOS—Docetaxel—lung cancer	0.000211	0.00134	CcSEcCtD
Fingolimod—Infestation—Docetaxel—lung cancer	0.000211	0.00134	CcSEcCtD
Fingolimod—Dyspnoea—Vinorelbine—lung cancer	0.000211	0.00133	CcSEcCtD
Fingolimod—Eye disorder—Paclitaxel—lung cancer	0.000209	0.00132	CcSEcCtD
Fingolimod—Cough—Irinotecan—lung cancer	0.000208	0.00132	CcSEcCtD
Fingolimod—Leukopenia—Gemcitabine—lung cancer	0.000208	0.00132	CcSEcCtD
Fingolimod—Cardiac disorder—Paclitaxel—lung cancer	0.000208	0.00132	CcSEcCtD
Fingolimod—Angiopathy—Etoposide—lung cancer	0.000207	0.00131	CcSEcCtD
Fingolimod—Hypertension—Irinotecan—lung cancer	0.000206	0.00131	CcSEcCtD
Fingolimod—Mediastinal disorder—Etoposide—lung cancer	0.000206	0.0013	CcSEcCtD
Fingolimod—Vision blurred—Cisplatin—lung cancer	0.000204	0.00129	CcSEcCtD
Fingolimod—Asthenia—Vinblastine—lung cancer	0.000204	0.00129	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000204	0.00129	CcSEcCtD
Fingolimod—Fatigue—Vinorelbine—lung cancer	0.000204	0.00129	CcSEcCtD
Fingolimod—Cough—Gemcitabine—lung cancer	0.000203	0.00129	CcSEcCtD
Fingolimod—Angiopathy—Paclitaxel—lung cancer	0.000203	0.00129	CcSEcCtD
Fingolimod—Alopecia—Etoposide—lung cancer	0.000202	0.00128	CcSEcCtD
Fingolimod—Mediastinal disorder—Paclitaxel—lung cancer	0.000202	0.00128	CcSEcCtD
Fingolimod—Cerebrovascular accident—Methotrexate—lung cancer	0.000202	0.00128	CcSEcCtD
Fingolimod—Hypertension—Gemcitabine—lung cancer	0.000201	0.00127	CcSEcCtD
Fingolimod—Asthenia—Topotecan—lung cancer	0.000198	0.00126	CcSEcCtD
Fingolimod—Alopecia—Paclitaxel—lung cancer	0.000198	0.00125	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000197	0.00125	CcSEcCtD
Fingolimod—Asthenia—Erlotinib—lung cancer	0.000196	0.00124	CcSEcCtD
Fingolimod—Mental disorder—Paclitaxel—lung cancer	0.000196	0.00124	CcSEcCtD
Fingolimod—Pruritus—Topotecan—lung cancer	0.000195	0.00124	CcSEcCtD
Fingolimod—Diarrhoea—Vinblastine—lung cancer	0.000195	0.00123	CcSEcCtD
Fingolimod—Leukopenia—Cisplatin—lung cancer	0.000194	0.00123	CcSEcCtD
Fingolimod—Infection—Irinotecan—lung cancer	0.000194	0.00123	CcSEcCtD
Fingolimod—Pruritus—Erlotinib—lung cancer	0.000193	0.00123	CcSEcCtD
Fingolimod—Back pain—Etoposide—lung cancer	0.000192	0.00122	CcSEcCtD
Fingolimod—Nervous system disorder—Irinotecan—lung cancer	0.000191	0.00121	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—lung cancer	0.00019	0.00121	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—lung cancer	0.00019	0.0012	CcSEcCtD
Fingolimod—Diarrhoea—Topotecan—lung cancer	0.000189	0.0012	CcSEcCtD
Fingolimod—Infection—Gemcitabine—lung cancer	0.000189	0.00119	CcSEcCtD
Fingolimod—Back pain—Paclitaxel—lung cancer	0.000188	0.00119	CcSEcCtD
Fingolimod—Dizziness—Vinblastine—lung cancer	0.000188	0.00119	CcSEcCtD
Fingolimod—Diarrhoea—Erlotinib—lung cancer	0.000187	0.00118	CcSEcCtD
Fingolimod—Connective tissue disorder—Docetaxel—lung cancer	0.000186	0.00118	CcSEcCtD
Fingolimod—Nervous system disorder—Gemcitabine—lung cancer	0.000186	0.00118	CcSEcCtD
Fingolimod—Skin disorder—Gemcitabine—lung cancer	0.000184	0.00117	CcSEcCtD
Fingolimod—Vision blurred—Paclitaxel—lung cancer	0.000184	0.00116	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000183	0.00116	CcSEcCtD
Fingolimod—Dizziness—Topotecan—lung cancer	0.000183	0.00116	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—lung cancer	0.000182	0.00116	CcSEcCtD
Fingolimod—Hypotension—Irinotecan—lung cancer	0.000182	0.00115	CcSEcCtD
Fingolimod—Dizziness—Erlotinib—lung cancer	0.000181	0.00115	CcSEcCtD
Fingolimod—Headache—Vinblastine—lung cancer	0.000178	0.00113	CcSEcCtD
Fingolimod—Leukopenia—Etoposide—lung cancer	0.000178	0.00113	CcSEcCtD
Fingolimod—Hypotension—Gemcitabine—lung cancer	0.000177	0.00112	CcSEcCtD
Fingolimod—Eye disorder—Docetaxel—lung cancer	0.000177	0.00112	CcSEcCtD
Fingolimod—Cardiac disorder—Docetaxel—lung cancer	0.000176	0.00111	CcSEcCtD
Fingolimod—Infection—Cisplatin—lung cancer	0.000176	0.00111	CcSEcCtD
Fingolimod—Paraesthesia—Irinotecan—lung cancer	0.000175	0.00111	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—lung cancer	0.000175	0.00111	CcSEcCtD
Fingolimod—Leukopenia—Paclitaxel—lung cancer	0.000174	0.0011	CcSEcCtD
Fingolimod—Dyspnoea—Irinotecan—lung cancer	0.000174	0.0011	CcSEcCtD
Fingolimod—Nervous system disorder—Cisplatin—lung cancer	0.000174	0.0011	CcSEcCtD
Fingolimod—Cough—Etoposide—lung cancer	0.000173	0.0011	CcSEcCtD
Fingolimod—Headache—Topotecan—lung cancer	0.000173	0.0011	CcSEcCtD
Fingolimod—Palpitations—Paclitaxel—lung cancer	0.000172	0.00109	CcSEcCtD
Fingolimod—Angiopathy—Docetaxel—lung cancer	0.000172	0.00109	CcSEcCtD
Fingolimod—Skin disorder—Cisplatin—lung cancer	0.000172	0.00109	CcSEcCtD
Fingolimod—Hypertension—Etoposide—lung cancer	0.000172	0.00109	CcSEcCtD
Fingolimod—Headache—Erlotinib—lung cancer	0.000171	0.00108	CcSEcCtD
Fingolimod—Mediastinal disorder—Docetaxel—lung cancer	0.000171	0.00108	CcSEcCtD
Fingolimod—Paraesthesia—Gemcitabine—lung cancer	0.00017	0.00108	CcSEcCtD
Fingolimod—Cough—Paclitaxel—lung cancer	0.00017	0.00108	CcSEcCtD
Fingolimod—Asthenia—Vinorelbine—lung cancer	0.00017	0.00107	CcSEcCtD
Fingolimod—Dyspnoea—Gemcitabine—lung cancer	0.000169	0.00107	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—lung cancer	0.000168	0.00107	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Irinotecan—lung cancer	0.000168	0.00107	CcSEcCtD
Fingolimod—Hypertension—Paclitaxel—lung cancer	0.000168	0.00107	CcSEcCtD
Fingolimod—Fatigue—Irinotecan—lung cancer	0.000168	0.00106	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000168	0.00106	CcSEcCtD
Fingolimod—Alopecia—Docetaxel—lung cancer	0.000168	0.00106	CcSEcCtD
Fingolimod—Pruritus—Vinorelbine—lung cancer	0.000167	0.00106	CcSEcCtD
Fingolimod—Mental disorder—Docetaxel—lung cancer	0.000166	0.00105	CcSEcCtD
Fingolimod—Hypotension—Cisplatin—lung cancer	0.000165	0.00105	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000165	0.00104	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000164	0.00104	CcSEcCtD
Fingolimod—Fatigue—Gemcitabine—lung cancer	0.000164	0.00104	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—lung cancer	0.000163	0.00103	CcSEcCtD
Fingolimod—Diarrhoea—Vinorelbine—lung cancer	0.000162	0.00102	CcSEcCtD
Fingolimod—Infection—Etoposide—lung cancer	0.000161	0.00102	CcSEcCtD
Fingolimod—Back pain—Docetaxel—lung cancer	0.00016	0.00101	CcSEcCtD
Fingolimod—Paraesthesia—Cisplatin—lung cancer	0.000159	0.00101	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—lung cancer	0.000158	0.001	CcSEcCtD
Fingolimod—Infection—Paclitaxel—lung cancer	0.000158	0.001	CcSEcCtD
Fingolimod—Dyspnoea—Cisplatin—lung cancer	0.000158	0.000999	CcSEcCtD
Fingolimod—Skin disorder—Etoposide—lung cancer	0.000157	0.000998	CcSEcCtD
Fingolimod—Dizziness—Vinorelbine—lung cancer	0.000156	0.00099	CcSEcCtD
Fingolimod—Nervous system disorder—Paclitaxel—lung cancer	0.000156	0.000988	CcSEcCtD
Fingolimod—Skin disorder—Paclitaxel—lung cancer	0.000154	0.000978	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000154	0.000976	CcSEcCtD
Fingolimod—Pneumonia—Methotrexate—lung cancer	0.000153	0.00097	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Cisplatin—lung cancer	0.000153	0.000968	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—lung cancer	0.000152	0.000965	CcSEcCtD
Fingolimod—Infestation—Methotrexate—lung cancer	0.000152	0.000965	CcSEcCtD
Fingolimod—Depression—Methotrexate—lung cancer	0.000152	0.000962	CcSEcCtD
Fingolimod—Hypotension—Etoposide—lung cancer	0.000151	0.00096	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000151	0.000956	CcSEcCtD
Fingolimod—Hypotension—Paclitaxel—lung cancer	0.000149	0.000941	CcSEcCtD
Fingolimod—Headache—Vinorelbine—lung cancer	0.000148	0.000938	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—lung cancer	0.000148	0.000937	CcSEcCtD
Fingolimod—Leukopenia—Docetaxel—lung cancer	0.000148	0.000936	CcSEcCtD
Fingolimod—Palpitations—Docetaxel—lung cancer	0.000146	0.000924	CcSEcCtD
Fingolimod—Paraesthesia—Etoposide—lung cancer	0.000146	0.000922	CcSEcCtD
Fingolimod—Dyspnoea—Etoposide—lung cancer	0.000145	0.000916	CcSEcCtD
Fingolimod—Cough—Docetaxel—lung cancer	0.000144	0.000913	CcSEcCtD
Fingolimod—Paraesthesia—Paclitaxel—lung cancer	0.000143	0.000904	CcSEcCtD
Fingolimod—Hypertension—Docetaxel—lung cancer	0.000143	0.000903	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—lung cancer	0.000142	0.000901	CcSEcCtD
Fingolimod—Dyspnoea—Paclitaxel—lung cancer	0.000142	0.000898	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Etoposide—lung cancer	0.00014	0.000887	CcSEcCtD
Fingolimod—Asthenia—Irinotecan—lung cancer	0.00014	0.000886	CcSEcCtD
Fingolimod—Fatigue—Etoposide—lung cancer	0.00014	0.000885	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00014	0.000884	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000137	0.000869	CcSEcCtD
Fingolimod—Fatigue—Paclitaxel—lung cancer	0.000137	0.000868	CcSEcCtD
Fingolimod—Asthenia—Gemcitabine—lung cancer	0.000136	0.000863	CcSEcCtD
Fingolimod—Pruritus—Gemcitabine—lung cancer	0.000134	0.000851	CcSEcCtD
Fingolimod—Infection—Docetaxel—lung cancer	0.000134	0.000848	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—lung cancer	0.000134	0.000847	CcSEcCtD
Fingolimod—Diarrhoea—Irinotecan—lung cancer	0.000133	0.000845	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—lung cancer	0.000133	0.00084	CcSEcCtD
Fingolimod—Nervous system disorder—Docetaxel—lung cancer	0.000132	0.000837	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—lung cancer	0.000132	0.000835	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—lung cancer	0.000132	0.000835	CcSEcCtD
Fingolimod—Skin disorder—Docetaxel—lung cancer	0.000131	0.000829	CcSEcCtD
Fingolimod—Diarrhoea—Gemcitabine—lung cancer	0.00013	0.000823	CcSEcCtD
Fingolimod—Dizziness—Irinotecan—lung cancer	0.000129	0.000816	CcSEcCtD
Fingolimod—Eye disorder—Methotrexate—lung cancer	0.000128	0.000809	CcSEcCtD
Fingolimod—Asthenia—Cisplatin—lung cancer	0.000127	0.000804	CcSEcCtD
Fingolimod—Cardiac disorder—Methotrexate—lung cancer	0.000127	0.000804	CcSEcCtD
Fingolimod—Hypotension—Docetaxel—lung cancer	0.000126	0.000798	CcSEcCtD
Fingolimod—Angiopathy—Methotrexate—lung cancer	0.000124	0.000786	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—lung cancer	0.000124	0.000784	CcSEcCtD
Fingolimod—Mediastinal disorder—Methotrexate—lung cancer	0.000123	0.00078	CcSEcCtD
Fingolimod—Headache—Irinotecan—lung cancer	0.000122	0.000773	CcSEcCtD
Fingolimod—Diarrhoea—Cisplatin—lung cancer	0.000121	0.000767	CcSEcCtD
Fingolimod—Paraesthesia—Docetaxel—lung cancer	0.000121	0.000766	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—lung cancer	0.000121	0.000765	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—lung cancer	0.00012	0.000763	CcSEcCtD
Fingolimod—Dyspnoea—Docetaxel—lung cancer	0.00012	0.000761	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—lung cancer	0.00012	0.000759	CcSEcCtD
Fingolimod—Headache—Gemcitabine—lung cancer	0.000119	0.000753	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Docetaxel—lung cancer	0.000116	0.000737	CcSEcCtD
Fingolimod—Asthenia—Etoposide—lung cancer	0.000116	0.000737	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—lung cancer	0.000116	0.000737	CcSEcCtD
Fingolimod—Fatigue—Docetaxel—lung cancer	0.000116	0.000736	CcSEcCtD
Fingolimod—Back pain—Methotrexate—lung cancer	0.000115	0.000729	CcSEcCtD
Fingolimod—Pruritus—Etoposide—lung cancer	0.000115	0.000727	CcSEcCtD
Fingolimod—Asthenia—Paclitaxel—lung cancer	0.000114	0.000722	CcSEcCtD
Fingolimod—Pruritus—Paclitaxel—lung cancer	0.000112	0.000712	CcSEcCtD
Fingolimod—Vision blurred—Methotrexate—lung cancer	0.000112	0.00071	CcSEcCtD
Fingolimod—Diarrhoea—Etoposide—lung cancer	0.000111	0.000703	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—lung cancer	0.000111	0.000701	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—lung cancer	0.00011	0.000696	CcSEcCtD
Fingolimod—Diarrhoea—Paclitaxel—lung cancer	0.000109	0.000689	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—lung cancer	0.000107	0.00068	CcSEcCtD
Fingolimod—Dizziness—Etoposide—lung cancer	0.000107	0.000679	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—lung cancer	0.000107	0.000676	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—lung cancer	0.000107	0.000675	CcSEcCtD
Fingolimod—Dizziness—Paclitaxel—lung cancer	0.000105	0.000666	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—lung cancer	0.000105	0.000663	CcSEcCtD
Fingolimod—Cough—Methotrexate—lung cancer	0.000104	0.000658	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—lung cancer	0.000104	0.000657	CcSEcCtD
Fingolimod—Headache—Etoposide—lung cancer	0.000102	0.000643	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000101	0.000637	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—lung cancer	9.97e-05	0.000631	CcSEcCtD
Fingolimod—Headache—Paclitaxel—lung cancer	9.96e-05	0.000631	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—lung cancer	9.71e-05	0.000615	CcSEcCtD
Fingolimod—Asthenia—Docetaxel—lung cancer	9.67e-05	0.000612	CcSEcCtD
Fingolimod—Infection—Methotrexate—lung cancer	9.65e-05	0.000611	CcSEcCtD
Fingolimod—Pruritus—Docetaxel—lung cancer	9.53e-05	0.000604	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—lung cancer	9.52e-05	0.000603	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—lung cancer	9.43e-05	0.000598	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—lung cancer	9.22e-05	0.000584	CcSEcCtD
Fingolimod—Diarrhoea—Docetaxel—lung cancer	9.22e-05	0.000584	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—lung cancer	9.11e-05	0.000577	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—lung cancer	9.07e-05	0.000575	CcSEcCtD
Fingolimod—Cough—Doxorubicin—lung cancer	8.99e-05	0.00057	CcSEcCtD
Fingolimod—Dizziness—Docetaxel—lung cancer	8.91e-05	0.000564	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—lung cancer	8.9e-05	0.000564	CcSEcCtD
Fingolimod—Paraesthesia—Methotrexate—lung cancer	8.72e-05	0.000552	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.71e-05	0.000552	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—lung cancer	8.66e-05	0.000548	CcSEcCtD
Fingolimod—Headache—Docetaxel—lung cancer	8.44e-05	0.000535	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Methotrexate—lung cancer	8.38e-05	0.000531	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—lung cancer	8.37e-05	0.00053	CcSEcCtD
Fingolimod—Infection—Doxorubicin—lung cancer	8.35e-05	0.000529	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—lung cancer	8.25e-05	0.000522	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—lung cancer	8.17e-05	0.000517	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—lung cancer	7.86e-05	0.000498	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—lung cancer	7.55e-05	0.000478	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—lung cancer	7.5e-05	0.000475	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—lung cancer	7.26e-05	0.00046	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—lung cancer	7.25e-05	0.000459	CcSEcCtD
Fingolimod—Asthenia—Methotrexate—lung cancer	6.97e-05	0.000441	CcSEcCtD
Fingolimod—Pruritus—Methotrexate—lung cancer	6.87e-05	0.000435	CcSEcCtD
Fingolimod—Diarrhoea—Methotrexate—lung cancer	6.64e-05	0.000421	CcSEcCtD
Fingolimod—Dizziness—Methotrexate—lung cancer	6.42e-05	0.000407	CcSEcCtD
Fingolimod—Headache—Methotrexate—lung cancer	6.08e-05	0.000385	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—lung cancer	6.03e-05	0.000382	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—lung cancer	5.95e-05	0.000377	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—lung cancer	5.75e-05	0.000364	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—lung cancer	5.56e-05	0.000352	CcSEcCtD
Fingolimod—Headache—Doxorubicin—lung cancer	5.27e-05	0.000334	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—lung cancer	1.57e-05	8.17e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—POMC—lung cancer	1.57e-05	8.16e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—lung cancer	1.57e-05	8.15e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—JUN—lung cancer	1.57e-05	8.14e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—lung cancer	1.57e-05	8.13e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	1.56e-05	8.1e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MTOR—lung cancer	1.55e-05	8.06e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CB—lung cancer	1.55e-05	8.06e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—lung cancer	1.55e-05	8.05e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SRC—lung cancer	1.55e-05	8.04e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SRC—lung cancer	1.55e-05	8.04e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—lung cancer	1.55e-05	8.03e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTMR3—lung cancer	1.54e-05	7.99e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—EP300—lung cancer	1.53e-05	7.94e-05	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—lung cancer	1.53e-05	7.92e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—lung cancer	1.53e-05	7.92e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1A—lung cancer	1.52e-05	7.89e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTEN—lung cancer	1.52e-05	7.87e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—lung cancer	1.51e-05	7.83e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—lung cancer	1.51e-05	7.83e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PGAM1—lung cancer	1.5e-05	7.79e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—lung cancer	1.49e-05	7.75e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—lung cancer	1.49e-05	7.75e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—lung cancer	1.49e-05	7.75e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—lung cancer	1.49e-05	7.73e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—lung cancer	1.49e-05	7.73e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK3—lung cancer	1.48e-05	7.69e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—lung cancer	1.48e-05	7.68e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—lung cancer	1.45e-05	7.55e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EP300—lung cancer	1.45e-05	7.51e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—lung cancer	1.44e-05	7.48e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	1.43e-05	7.44e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2A7—lung cancer	1.43e-05	7.43e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—lung cancer	1.43e-05	7.41e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK3—lung cancer	1.43e-05	7.41e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK3—lung cancer	1.43e-05	7.41e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—lung cancer	1.43e-05	7.4e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—lung cancer	1.41e-05	7.32e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SRC—lung cancer	1.41e-05	7.3e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLBD1—lung cancer	1.41e-05	7.29e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SDC4—lung cancer	1.4e-05	7.27e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—lung cancer	1.39e-05	7.22e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—lung cancer	1.39e-05	7.2e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—lung cancer	1.39e-05	7.2e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—JUN—lung cancer	1.39e-05	7.2e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.38e-05	7.15e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—lung cancer	1.37e-05	7.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.36e-05	7.06e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—lung cancer	1.36e-05	7.05e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—lung cancer	1.36e-05	7.05e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—lung cancer	1.36e-05	7.04e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—lung cancer	1.35e-05	7.02e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—lung cancer	1.35e-05	7.01e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1A—lung cancer	1.35e-05	6.98e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTEN—lung cancer	1.34e-05	6.97e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—lung cancer	1.33e-05	6.91e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—lung cancer	1.32e-05	6.84e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK3—lung cancer	1.3e-05	6.73e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSD17B10—lung cancer	1.29e-05	6.67e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—lung cancer	1.28e-05	6.66e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—lung cancer	1.28e-05	6.66e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EP300—lung cancer	1.28e-05	6.64e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RRM1—lung cancer	1.28e-05	6.62e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA3—lung cancer	1.28e-05	6.62e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—lung cancer	1.26e-05	6.54e-05	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—lung cancer	1.25e-05	6.47e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SRC—lung cancer	1.24e-05	6.46e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—lung cancer	1.23e-05	6.4e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—lung cancer	1.22e-05	6.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AZIN2—lung cancer	1.21e-05	6.29e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.21e-05	6.29e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—lung cancer	1.21e-05	6.29e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—lung cancer	1.2e-05	6.23e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—B4GALT5—lung cancer	1.2e-05	6.23e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—lung cancer	1.2e-05	6.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CKB—lung cancer	1.2e-05	6.2e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—lung cancer	1.18e-05	6.15e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	6.12e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	6.12e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA4—lung cancer	1.17e-05	6.06e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—lung cancer	1.16e-05	6.04e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK3—lung cancer	1.15e-05	5.95e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—lung cancer	1.14e-05	5.92e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—lung cancer	1.14e-05	5.92e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA2—lung cancer	1.14e-05	5.9e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—lung cancer	1.13e-05	5.88e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—lung cancer	1.13e-05	5.88e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM2—lung cancer	1.12e-05	5.83e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CNDP2—lung cancer	1.12e-05	5.83e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—lung cancer	1.12e-05	5.79e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA1—lung cancer	1.1e-05	5.7e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTMR3—lung cancer	1.09e-05	5.67e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—lung cancer	1.09e-05	5.66e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—lung cancer	1.09e-05	5.66e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—lung cancer	1.09e-05	5.66e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCC3—lung cancer	1.09e-05	5.63e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—lung cancer	1.08e-05	5.63e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—lung cancer	1.08e-05	5.59e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—lung cancer	1.07e-05	5.55e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PGAM1—lung cancer	1.07e-05	5.53e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKR1C1—lung cancer	1.05e-05	5.45e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—lung cancer	1.04e-05	5.41e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—lung cancer	1.04e-05	5.41e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—lung cancer	1.04e-05	5.37e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ATP5H—lung cancer	1.03e-05	5.35e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—lung cancer	1.03e-05	5.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—POMC—lung cancer	1.03e-05	5.33e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—UGT1A1—lung cancer	1.02e-05	5.3e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2A7—lung cancer	1.02e-05	5.27e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—lung cancer	1e-05	5.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SDC4—lung cancer	9.95e-06	5.16e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—lung cancer	9.9e-06	5.14e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNG11—lung cancer	9.84e-06	5.11e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—lung cancer	9.63e-06	5e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—lung cancer	9.63e-06	5e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—lung cancer	9.48e-06	4.92e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—lung cancer	9.47e-06	4.91e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDOA—lung cancer	9.37e-06	4.86e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—lung cancer	9.25e-06	4.8e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLBD1—lung cancer	9.19e-06	4.77e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—lung cancer	9.16e-06	4.75e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOA3—lung cancer	9.1e-06	4.72e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RRM1—lung cancer	9.06e-06	4.7e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA3—lung cancer	9.06e-06	4.7e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADCY1—lung cancer	8.85e-06	4.59e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCG2—lung cancer	8.85e-06	4.59e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—lung cancer	8.76e-06	4.55e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—lung cancer	8.74e-06	4.54e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HPGDS—lung cancer	8.68e-06	4.5e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO2—lung cancer	8.68e-06	4.5e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPP2R1B—lung cancer	8.62e-06	4.47e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—B4GALT5—lung cancer	8.52e-06	4.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—lung cancer	8.42e-06	4.37e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD17B10—lung cancer	8.41e-06	4.36e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—lung cancer	8.39e-06	4.35e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GCLC—lung cancer	8.32e-06	4.32e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2A6—lung cancer	8.32e-06	4.32e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA4—lung cancer	8.28e-06	4.3e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA2—lung cancer	8.07e-06	4.19e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO1—lung cancer	7.89e-06	4.09e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CKB—lung cancer	7.81e-06	4.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA1—lung cancer	7.79e-06	4.04e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—lung cancer	7.74e-06	4.01e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCC3—lung cancer	7.7e-06	4e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKR1C1—lung cancer	7.46e-06	3.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CNDP2—lung cancer	7.35e-06	3.81e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM2—lung cancer	7.35e-06	3.81e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UGT1A1—lung cancer	7.24e-06	3.76e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTMR3—lung cancer	7.15e-06	3.71e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NQO1—lung cancer	6.99e-06	3.63e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNG11—lung cancer	6.98e-06	3.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PGAM1—lung cancer	6.96e-06	3.61e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDOA—lung cancer	6.65e-06	3.45e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2A7—lung cancer	6.64e-06	3.45e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SDC4—lung cancer	6.5e-06	3.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOA3—lung cancer	6.45e-06	3.35e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—STK11—lung cancer	6.3e-06	3.27e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADCY1—lung cancer	6.28e-06	3.26e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCG2—lung cancer	6.28e-06	3.26e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO2—lung cancer	6.16e-06	3.2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HPGDS—lung cancer	6.16e-06	3.2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPP2R1B—lung cancer	6.12e-06	3.17e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—lung cancer	5.97e-06	3.1e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RRM1—lung cancer	5.92e-06	3.07e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA3—lung cancer	5.92e-06	3.07e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCLC—lung cancer	5.9e-06	3.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2A6—lung cancer	5.9e-06	3.06e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—lung cancer	5.83e-06	3.03e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CAT—lung cancer	5.68e-06	2.95e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO1—lung cancer	5.6e-06	2.9e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—B4GALT5—lung cancer	5.57e-06	2.89e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—lung cancer	5.52e-06	2.87e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMS—lung cancer	5.42e-06	2.81e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA4—lung cancer	5.42e-06	2.81e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—lung cancer	5.36e-06	2.78e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA2—lung cancer	5.28e-06	2.74e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA1—lung cancer	5.09e-06	2.64e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1A1—lung cancer	5.08e-06	2.64e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ERCC2—lung cancer	5.04e-06	2.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCC3—lung cancer	5.04e-06	2.61e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2E1—lung cancer	5.02e-06	2.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NQO1—lung cancer	4.96e-06	2.58e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKR1C1—lung cancer	4.88e-06	2.53e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UGT1A1—lung cancer	4.73e-06	2.46e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNG11—lung cancer	4.57e-06	2.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—STK11—lung cancer	4.47e-06	2.32e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOA1—lung cancer	4.36e-06	2.26e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDOA—lung cancer	4.35e-06	2.26e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOA3—lung cancer	4.22e-06	2.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—lung cancer	4.14e-06	2.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADCY1—lung cancer	4.1e-06	2.13e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCG2—lung cancer	4.1e-06	2.13e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CAT—lung cancer	4.03e-06	2.09e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPGDS—lung cancer	4.03e-06	2.09e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO2—lung cancer	4.03e-06	2.09e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPP2R1B—lung cancer	4e-06	2.08e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—lung cancer	3.98e-06	2.07e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—lung cancer	3.92e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—lung cancer	3.9e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2A6—lung cancer	3.86e-06	2e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCLC—lung cancer	3.86e-06	2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMS—lung cancer	3.85e-06	2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—lung cancer	3.8e-06	1.97e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—POMC—lung cancer	3.79e-06	1.97e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CREBBP—lung cancer	3.69e-06	1.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO1—lung cancer	3.66e-06	1.9e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1A1—lung cancer	3.61e-06	1.87e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ERCC2—lung cancer	3.58e-06	1.86e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CD—lung cancer	3.5e-06	1.82e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—lung cancer	3.45e-06	1.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2E1—lung cancer	3.28e-06	1.7e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NQO1—lung cancer	3.24e-06	1.68e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOA1—lung cancer	3.09e-06	1.61e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CB—lung cancer	3.05e-06	1.58e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—lung cancer	3.02e-06	1.57e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—STK11—lung cancer	2.92e-06	1.52e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—lung cancer	2.82e-06	1.47e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—lung cancer	2.71e-06	1.4e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—POMC—lung cancer	2.69e-06	1.4e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—lung cancer	2.64e-06	1.37e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CAT—lung cancer	2.63e-06	1.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CREBBP—lung cancer	2.62e-06	1.36e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—lung cancer	2.56e-06	1.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMS—lung cancer	2.52e-06	1.31e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—EP300—lung cancer	2.51e-06	1.3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—lung cancer	2.49e-06	1.29e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CD—lung cancer	2.48e-06	1.29e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—lung cancer	2.45e-06	1.27e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1A1—lung cancer	2.36e-06	1.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ERCC2—lung cancer	2.34e-06	1.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CB—lung cancer	2.16e-06	1.12e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—lung cancer	2.14e-06	1.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOA1—lung cancer	2.02e-06	1.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—lung cancer	1.87e-06	9.7e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—lung cancer	1.86e-06	9.65e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—lung cancer	1.85e-06	9.58e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EP300—lung cancer	1.78e-06	9.26e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—POMC—lung cancer	1.76e-06	9.12e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CREBBP—lung cancer	1.71e-06	8.88e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CD—lung cancer	1.62e-06	8.42e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—lung cancer	1.6e-06	8.32e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—lung cancer	1.52e-06	7.88e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CB—lung cancer	1.42e-06	7.34e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—lung cancer	1.4e-06	7.28e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—lung cancer	1.32e-06	6.85e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—lung cancer	1.22e-06	6.35e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EP300—lung cancer	1.17e-06	6.05e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—lung cancer	1.08e-06	5.59e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—lung cancer	8.63e-07	4.48e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—lung cancer	7.05e-07	3.66e-06	CbGpPWpGaD
